Acrivon Therapeutics, Inc. Common Stock
USD1.51
-0.06 (-3.82%)
CEO
Peter Blume-Jensen
IPO Date
2022-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.55
Prev. Close
$1.57
Day Low
$1.51
Day High
$1.60
52W Low
$1.15
52W High
$3.56
Market Cap
$0.05B
Volume
0.29M
| 9,366 |
| $0.00 |
| 20 May 2026 | Shacham Sharon | director | A-Award | Acquired | 9,366 | $0.00 |
| 20 May 2026 | Palani Santhosh | director | A-Award | Acquired | 9,366 | $0.00 |
| 20 May 2026 | Magovcevic-Liebisch Ivana | director | A-Award | Acquired | 9,366 | $0.00 |
| 20 May 2026 | DiRocco Derek | director | A-Award | Acquired | 9,366 | $0.00 |
| 20 May 2026 | BAUM CHARLES M | director | A-Award | Acquired | 9,366 | $0.00 |
| 20 May 2026 | Peterson Katharine | Chief Accounting Officer | A-Award | Acquired | 14,227 | $0.00 |
| 20 May 2026 | Mirza Mansoor Raza | Chief Medical Officer | A-Award | Acquired | 38,817 | $0.00 |
| 20 May 2026 | Miller Mary | Chief Legal Officer | A-Award | Acquired | 49,830 | $0.00 |